Stocks like NVDA can be traded onchain with iAssets, while Libre Capital expands Injective's reach to institutions
The Injective Overview - March 10, 2025
Welcome back to the Injective Overview.
We’re creating the best place for the Injective community to get the latest updates, metrics, insights and ecosystem developments and more – all in one place.
Note: Sign up for Injective Summit in NYC on June 26, 2025
New here? Subscribe to get updates to your inbox. Every other Monday.
Injective By the Numbers
$INJ price: $10.16 (-33.38%)
Token market cap: $1.01B (-32.67%)
Total token holders: 50.74K (-0.28%)
Total $INJ staked: 58.79M (-0.36%)
Staking APR: 11.65% (+0.26%)
Injective daily trading volume: $20.4M (-83%)
The percentages and metrics are calculated from its change over a 14-day time frame, unless noted otherwise.
Injecting in the biggest developments
Highlighting some of the largest announcements from Injective.
Injective introduced iAssets, a solution aimed at improving composability and capital efficiency within decentralized markets.
This onchain asset class is designed to improve liquidity options for users, while eliminating pre-funding requirements that might limit a trader’s ability to transact. Traditionally, accessing assets like gold or silver onchain required a user to lock up their funds. But with iAssets, traders can gain more flexibility and unlock DeFi opportunities such as hedging, lending and yield generation.
On day one of the release of iAssets, Injective deployed support for Nvidia’s stock NVDA as the first iAsset – seeing $10.3 million in trading volume in the first hours post-launch. This can be seen as a pivotal move in order to achieve the goal of more efficient capital markets, alongside mainstream big tech assets.
Since iAssets leverages Injective’s infrastructure, it can provide more interoperable choices for onchain finance. By integrating with the network, its goal is to enable real-time price feeds for equities, as well as stablecoin-based trading pairs and shared liquidity across networks to respond to market demand.
If this product can attract a diverse user base such as institutional traders, liquidity providers and developers, Injective can position itself as a key player in decentralized financial infrastructure. In turn, this can grow the chain’s market share in the decentralized derivatives and tokenization sectors to expand financial innovation.
Libre Capital expanded its institutional platform to the Injective network.
The fund issuance platform allows accredited investors to access tokenized versions of institutional-grade funds via blockchain technology. While Libre has already deployed to multiple networks, its expansion to Injective looks to leverage its RWA module so tokenized assets can be used within DeFi applications.
Libre lets asset managers like BlackRock and Brevan Howard access tokenized versions of private credit, hedge funds and money market products. This is important because these funds can utilize additional financial avenues they might not have been able to access without the usage of blockchain technology.
Injective looks to accelerate the movement to bring real-world assets onto the blockchain by offering Libre’s institutional-grade tokenized funds to its ecosystem. As more capital flows into onchain finance and institutions explore blockchain-based financial products, initiatives like Libre and infrastructures like Injective can bridge the gap between DeFi and traditional finance.
Expanding its financial ecosystem
Updates on the latest network of dApps, validators, builders and more helping Injective expand its financial use cases.
Injective’s 191st burn round ended on March 5 with $118.1K in INJ being removed from circulation, tightening the token’s supply
The 192nd burn round ends on March 12 - participate here
Deutsche Telekom, the telecommunications companies behind T-Mobile, became a validator for Injective
Helix deployed an update to its trading platform so users can earn yield on unused funds while still maintaining liquidity
The network hit an all-time high in daily transactions on Feb. 25, 6.8 million (shown below)
It also hit 38.2K daily active addresses on March 9, a 664% increase YTD
Source: Artemis
From the Injective ninjas 🥷
Highlighting the builders, communities and ecosystem players within the Injective blockchain.
ICYMI: Learn how Timeworx looks to help automate data processing for businesses, via an X space
Want to dive deeper into it? Injective posted about its integration to the network
Helix hit 37.59K unique active wallets, rising 81% over the past 7-days, DappRadar data shows
Injective CTO Albert Chon spoke at ETHDenver about the Injective’s Multi-VM support initiative
For more Injective updates, check out its blog here.
By the headlines
You might have seen these Injective-related headlines recently…
Injective Co-Founder and CEO Eric Chen spoke at the NYSE about the team’s goal to tokenize all assets
T-Mobile parent Deutsche Telekom joins Binance-incubated Injective as validator (The Block)
Dive deeper into Injective
Want to get involved in the ecosystem? Developers can check out documentation, GitHub and more here. Find the latest job postings here or get involved at an event below.
Participate in Bitget Wallet’s campaign with Injective and its dApps to win a share of a $100K prize pool
To get this newsletter delivered to your inbox every Monday. Subscribe here.
This product was built by Token Relations.
This information is for entertainment purposes only. It should not be considered financial advice, nor should it be used to make investment decisions. Cryptocurrencies are high risk and you should consult a financial professional before making any financial decisions. Make sure you do your own research.